Molecular Partners AGOver The Counter Market:MLLCF
- LAST PRICE3.8000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 3.8000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Apr 29, 2024
Apr 19, 2024
Life Science Cares Launches in Switzerland, from 11:12AM ET on Friday Apr 19, 2024 by Dow Jones
11:12AM ET on Friday Apr 19, 2024 by Dow JonesLife Science Cares Launches in Switzerland, from 11:12AM ET on Friday Apr 19, 2024 by Dow Jones
11:12AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Press Release: Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting, from 11:12AM ET on Wednesday Apr 17, 2024 by Dow Jones
11:12AM ET on Wednesday Apr 17, 2024 by Dow JonesMolecular Partners Announces All Board Proposals Approved at the Annual General Meeting, from 11:12AM ET on Wednesday Apr 17, 2024 by Dow Jones
11:12AM ET on Wednesday Apr 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Molecular Partners AG | 123.7M | 0.0x | --- |
Company Information
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Contact Information
- Headquarters
- Wagistrasse 14SCHLIEREN, Switzerland 8952
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $123.7M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 36.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.34 |
EPS | $-1.89 |
Book Value | $5.37 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 17.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -868.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
